Effect of hypoxia on Ad5 infection, transgene expression and replication (original) (raw)
Williams DA, Smith FO . Progress in the use of gene transfer methods to treat genetic blood diseases. Hum Gene Ther 2000; 11: 2059–2066. ArticleCASPubMed Google Scholar
Swisher SG et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 2003; 9: 93–101. CASPubMed Google Scholar
Buller RE et al. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Ther 2002; 9: 553–566. ArticleCASPubMed Google Scholar
Kirn D . Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer. Oncogene 2000; 19: 6660–6669. ArticleCASPubMed Google Scholar
Hermiston T . Fighting fire with fire: attacking the complexity of human tumors with armed therapeutic viruses. Curr Opin Mol Ther 2002; 4: 334–342. CASPubMed Google Scholar
Semenza GL et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000; 475: 123–130. ArticleCASPubMed Google Scholar
Niinikoski J . Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making. Wound Repair Regen 2003; 11: 458–461. ArticlePubMed Google Scholar
Zauner A, Daugherty WP, Bullock MR, Warner DS . Brain oxygenation and energy metabolism: part I – biological function and pathophysiology. Neurosurgery 2002; 51: 289–301; discussion 302. PubMed Google Scholar
Wouters BG et al. Hypoxia as a target for combined modality treatments. Eur J Cancer 2002; 38: 240–257. ArticleCASPubMed Google Scholar
Brown JM . The hypoxic cell: a target for selective cancer therapy – eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999; 59: 5863–5870. CASPubMed Google Scholar
Graeber TG et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88–91. ArticleCASPubMed Google Scholar
Wouters BG et al. Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol 2003; 13: 31–41. ArticlePubMed Google Scholar
Brown JM, Giaccia AJ . The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408–1416. CASPubMed Google Scholar
Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW . Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 1998; 201 (Part 8): 1153–1162. CASPubMed Google Scholar
Giaccia A, Siim BG, Johnson RS . HIF-1 as a target for drug development. Nat Rev Drug Discov 2003; 2: 803–811. ArticleCASPubMed Google Scholar
Post DE, Van Meir EG . A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy. Oncogene 2003; 22: 2065–2072. ArticleCASPubMed Google Scholar
Aebersold DM et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911–2916. CASPubMed Google Scholar
Vukovic V et al. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res 2001; 61: 7394–7398. CASPubMed Google Scholar
Wenger RH et al. Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int 1997; 51: 560–563. ArticleCASPubMed Google Scholar
Shenk T . Adenoviridae: the virus and their replication. In: Knipe D, Howley, PM (eds). Fields Virology. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 2266. Google Scholar
Howitt J, Anderson CW, Freimuth P . Adenovirus interaction with its cellular receptor CAR. Curr Top Microbiol Immunol 2003; 272: 331–364. CASPubMed Google Scholar
Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–1323. ArticleCASPubMed Google Scholar
Triantafilou K, Takada Y, Triantafilou M . Mechanisms of integrin-mediated virus attachment and internalization process. Crit Rev Immunol 2001; 21: 311–322. ArticleCASPubMed Google Scholar
Wickham TJ, Mathias P, Cheresh DA, Nemerow GR . Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309–319. ArticleCASPubMed Google Scholar
Noutsias M et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001; 104: 275–280. ArticleCASPubMed Google Scholar
Summerford C, Bartlett JS, Samulski RJ . AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78–82. ArticleCASPubMed Google Scholar
Dechecchi MC et al. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001; 75: 8772–8780. ArticleCASPubMedPubMed Central Google Scholar
Hong SS et al. Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity. Hum Gene Ther 1999; 10: 2577–2586. ArticleCASPubMed Google Scholar
Davison E et al. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function. J Gene Med 2001; 3: 550–559. ArticleCASPubMed Google Scholar
Miyazawa N et al. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol 1999; 73: 6056–6065. CASPubMedPubMed Central Google Scholar
Goldsmith KT, Curiel DT, Engler JA, Garver Jr RI . Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells. Hum Gene Ther 1994; 5: 1341–1348. ArticleCASPubMed Google Scholar
White JR et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 2004; 83: 1–8. ArticleCASPubMed Google Scholar
Ning W et al. Genome wide analysis of the endothelial transcriptome under short-term chronic hypoxia. Physiol Genomics 2004; 18: 70–78. ArticleCASPubMed Google Scholar
Amano H, Maruyama K, Naka M, Tanaka T . Target validation in hypoxia-induced vascular remodeling using transcriptome/metabolome analysis. Pharmacogenomics J 2003; 3: 183–188. ArticleCASPubMed Google Scholar
Hawkins LK, Lemoine NR, Kirn D . Oncolytic biotherapy: a novel therapeutic plafform. Lancet Oncol 2002; 3: 17–26. ArticleCASPubMed Google Scholar
Kanerva A, Hemminki A . Modified adenoviruses for cancer gene therapy. Int J Cancer 2004; 110: 475–480. ArticleCASPubMed Google Scholar
Kirn D, Niculescu-Duvaz I, Hallden G, Springer CJ . The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 2002; 8: S68–S73. ArticleCASPubMed Google Scholar
Post DE, Khuri FR, Simons JW, Van Meir EG . Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003; 14: 933–946. ArticleCASPubMed Google Scholar
Nettelbeck DM . Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis. Anticancer Drugs 2003; 14: 577–584. ArticleCASPubMed Google Scholar
Hitt MM, Graham FL . Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication. Virology 1990; 179: 667–678. ArticleCASPubMed Google Scholar
Schmaltz C, Hardenbergh PH, Wells A, Fisher DE . Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 1998; 18: 2845–2854. ArticleCASPubMedPubMed Central Google Scholar
Freyer JP, Sutherland RM . Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply. Cancer Res 1986; 46: 3513–3520. CASPubMed Google Scholar
Bellett AJ et al. Control functions of adenovirus transformation region E1A gene products in rat and human cells. Mol Cell Biol 1985; 5: 1933–1939. ArticleCASPubMedPubMed Central Google Scholar
Bellett AJ et al. Functions of the two adenovirus early E1A proteins and their conserved domains in cell cycle alteration, actin reorganization, and gene activation in rat cells. J Virol 1989; 63: 303–310. CASPubMedPubMed Central Google Scholar
Binley K et al. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Therapy 1999; 6: 1721–1727. ArticleCASPubMed Google Scholar
Kaliberov SA et al. Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells. Mol Ther 2002; 6: 190–198. ArticleCASPubMed Google Scholar
Goda N, Dozier SJ, Johnson RS . HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 2003; 5: 467–473. ArticleCASPubMed Google Scholar
Ben-Israel H, Kleinberger T . Adenovirus and cell cycle control. Front Biosci 2002; 7: d1369–d1395. ArticleCASPubMed Google Scholar
Fukuda K et al. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer. Cancer Res 2003; 63: 4434–4440. CASPubMed Google Scholar
Holm PS et al. Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Res 2004; 64: 322–328. ArticleCASPubMed Google Scholar
Kim E et al. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner. Hum Gene Ther 2003; 14: 1415–1428. ArticleCASPubMed Google Scholar
Wold W . Adenovirus Methods and Protocols. Humana Press Inc.: Totowa, NJ, 1998. Book Google Scholar
Grines CL et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291–1297. ArticleCASPubMed Google Scholar